1Johnson BD, Truitt RL. Delayed infusion of immunocompetent donor cell after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemia reactivity without severe graft-versus-host disease.Blood, 1995,85: 3302-3312.
2Porter DL, Antin JH. Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia. Hematol Oncol Clin of North Am, 1998,12: 123-150.
3Truitt RL, Alasoylu AA. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood, 1991,77 : 2515-2523.
